Stryker 1Q Sales, Profit Rise as it Dealt with Cyberattack

By Paul Ziobro


Stryker posted higher profit and sales in the first quarter, during which it was hit by a cyberattack that reportedly was in retaliation to the war in Iran.

The medical-device company on Thursday posted a profit of $745 million, or $1.93 a share, compared with $654 million, or $1.69 a share, in the same quarter a year ago.

Adjusted earnings were $2.60 a share. Analysts polled by FactSet expected $2.98 a share.

Sales rose 2.6% to $6.02 billion, short of the $6.34 billion expected by analysts. Sales rose 5% in its MedSurg and Neurotechnology units and edged 0.1% higher in Orthopaedics.

Stryker in March was hit by a cyberattack, which caused a global disruption to its Microsoft systems. The hackers behind the attack said they were retaliating on behalf of Iran as the conflict with the U.S. was escalating, The Wall Street Journal reported at the time.

Stryker said earlier this month said that the incident would impact its first-quarter results, but not its full-year financials.

Stryker on Thursday also backed its full-year outlook.

Shares of Stryker fell 2% in late trading to $308.75.


Write to Paul Ziobro at paul.ziobro@wsj.com

-0- 

Outlook

net sales 8-9.5%

Adjusted EPS 14.90 to $15.10

(END) Dow Jones Newswires

April 30, 2026 16:41 ET (20:41 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.

Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.

Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.

Popular

Sponsor Center